Efficacy News and Research

RSS
New shingles vaccine gets FDA panel votes

New shingles vaccine gets FDA panel votes

Novel technology holds promise for improving accuracy of type 1 diabetes tests

Novel technology holds promise for improving accuracy of type 1 diabetes tests

Combination immunotherapy shows better overall survival in kidney cancer patients

Combination immunotherapy shows better overall survival in kidney cancer patients

Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes

Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

Study adds more evidence that racial, socioeconomic disparities may occur during surgical pain management

Study adds more evidence that racial, socioeconomic disparities may occur during surgical pain management

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Young men have lowest risk of relapse after antireflux surgery, study finds

Young men have lowest risk of relapse after antireflux surgery, study finds

New medication shows potential to reduce fracture risk in women with osteoporosis

New medication shows potential to reduce fracture risk in women with osteoporosis

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Tracking eye movements offers new method for monitoring temporal expectation in ADHD

Tracking eye movements offers new method for monitoring temporal expectation in ADHD

Study findings may have critical implications to boost efficacy of T cell-based therapies

Study findings may have critical implications to boost efficacy of T cell-based therapies

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Meningitis B vaccine’s high price tag poses a health care conundrum

Meningitis B vaccine’s high price tag poses a health care conundrum

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

Internet-based IRT may be effective treatment to improve nightmare distress

Internet-based IRT may be effective treatment to improve nightmare distress

Self-help preventive cognitive therapy found to be effective in reducing recurrent depression

Self-help preventive cognitive therapy found to be effective in reducing recurrent depression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.